Bio-Techne (TECH) Other Non Operating Income (2009 - 2023)
Bio-Techne (TECH) recorded quarterly Other Non Operating Income of -$3.5 million in Q2 2023, down 1037.04% quarter-over-quarter from $378000.0 in Q1 2023, and down 544.97% on a YoY basis from $796000.0 in Q2 2022.
Bio-Techne (TECH) Other Non Operating Income (2009 - 2023) Analysis & Trends
Bio-Techne's Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$3.5 million for Q2 2023.
- In Q2 2023, Other Non Operating Income fell 544.97% year-over-year to -$3.5 million; the TTM figure through Jun 2023 stood at $47.5 million (up 210.35% YoY), while the FY2025 annual figure was $831000.0, up 109.68% from the prior year.
- Other Non Operating Income was -$3.5 million for Q2 2023 at Bio-Techne, down from $378000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $118.0 million in Q4 2019 to a low of -$58.3 million in Q2 2021.
- Historically, Other Non Operating Income has averaged $6.7 million across 5 years, with a median of $587000.0 in 2022.
- Biggest YoY gain for Other Non Operating Income was 2005.59% in 2019; the steepest drop was 25355.0% in 2019.
- A 5-year view of Other Non Operating Income shows it stood at $118.0 million in 2019, then plunged by 92.47% to $8.9 million in 2020, then surged by 198.29% to $26.5 million in 2021, then sank by 100.28% to -$74000.0 in 2022, then sank by 4686.49% to -$3.5 million in 2023.
- The last three Other Non Operating Income figures came in at -$3.5 million (Q2 2023), $378000.0 (Q1 2023), and -$74000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -3.54 Mn |
| Mar 31, 2023 | 378,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | 50.76 Mn |
| Jun 30, 2022 | 796,000.00 |
| Mar 31, 2022 | -19.35 Mn |
| Dec 31, 2021 | 26.49 Mn |
| Sep 30, 2021 | 7.38 Mn |
| Jun 30, 2021 | -58.35 Mn |
| Mar 31, 2021 | -20.73 Mn |
| Dec 31, 2020 | 8.88 Mn |
| Sep 30, 2020 | -5.45 Mn |
| Jun 30, 2020 | 26.71 Mn |
| Mar 31, 2020 | 3.37 Mn |
| Dec 31, 2019 | 117.98 Mn |
| Sep 30, 2019 | -10.41 Mn |
| Jun 30, 2019 | -15.15 Mn |
| Mar 31, 2019 | 10.82 Mn |
| Dec 31, 2018 | -6.19 Mn |
| Sep 30, 2018 | -3.04 Mn |